In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control

• Anastasia Felker ,

  Contributed equally to this work with: Anastasia Felker, Susan Nieuwenhuize

  Affiliation Institute of Molecular Life Sciences, University of Zürich, Zürich, Switzerland

  ⨯
• Susan Nieuwenhuize ,

  Contributed equally to this work with: Anastasia Felker, Susan Nieuwenhuize

  Affiliation Institute of Molecular Life Sciences, University of Zürich, Zürich, Switzerland

  ⨯
• Aymeric Dolbois,

  Affiliation Department of Chemistry, University of Zürich, Zürich, Switzerland

  ⨯
• Kristyna Blazkova,

  Affiliation CZ-OPENSCREEN, Institute of Molecular Genetics of the ASCR, v.v.i., Prague, Czech Republic

  ⨯
• Christopher Hess,

  Affiliation Institute of Molecular Life Sciences, University of Zürich, Zürich, Switzerland

  ⨯
• Larry W. L. Low,

  Affiliation Institute of Molecular and Cell Biology (IMCB), A*STAR, Biopolis Drive, Singapore, Singapore

  ⨯
• Sibylle Burger,

  Affiliation Institute of Molecular Life Sciences, University of Zürich, Zürich, Switzerland

  ⨯
• Natasha Samson,

  Affiliation Institute of Molecular Life Sciences, University of Zürich, Zürich, Switzerland

  ⨯
• Tom J. Carney,

  Affiliations Institute of Molecular and Cell Biology (IMCB), A*STAR, Biopolis Drive, Singapore, Singapore, Lee Kong Chian School of Medicine, Nanyang Technological University, 50 Nanyang Avenue, Singapore, Singapore

  ⨯
• Petr Bartunek,

  Affiliation CZ-OPENSCREEN, Institute of Molecular Genetics of the ASCR, v.v.i., Prague, Czech Republic

  ⨯
• Cristina Nevado,

  Affiliation Department of Chemistry, University of Zürich, Zürich, Switzerland

  ⨯
• Christian Mosimann

  * E-mail: christian.mosimann@imls.uzh.ch

  Affiliation Institute of Molecular Life Sciences, University of Zürich, Zürich, Switzerland

  http://orcid.org/0000-0002-0749-2576

  ⨯